// App-Quantinova.ai

Su1560 : Timing of Pre-Operative Anti-Tumor Necrosis Factor Therapy Does Not Affect Early Post-Operative Complication Rates in Inflammatory Bowel Disease Patients Undergoing Intestinal Resection

Researchers

Presenter

  • Anil Sharma

Principal Investigators

  • Amar S. Naik

  • Mary F. Otterson

  • Yelena Zadvornova

  • Lilani P. Perera

  • Nanda Venu

  • Daniel J. Stein

Medical Centers

  • The Medical College of Wisconsin, Milwaukee, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Inflammatory bowel disease

  • Acute renal failure

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Budesonide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved